This application is for the continuance of R37GM54060, a Merit Award initially awarded as an ROI in 1994. The purpose of this grant is to determine how LPS recognition results in the syndrome of Gram-negative sepsis. The current cycle proposed four Specific Aims: 1) To characterize MD-2, 2) To characterize the fine details of TLR4/MD-2 receptor activation, 3) To characterize the TLR4 adapters: MyD88, Mai, TRIP and TRAM, 4) To define the biology of MD-2 in vivo. We have published 17 papers attributable to R37GM54060 so far in this funding cycle, and addressed most of the major issues in its Aims. We have reported on the opsonic activity of MD-2 and worked out the fine details of TLR4/MD-2 receptor activation. We have characterized important aspects of MyD88 and Mai interaction and function. We have definitively addressed the issue of altemative LPS receptors in macrophages. We have yet to generate a Mab to MD-2, although immunizations are in progress. We will launch our studies on the in vivo role of MD-2 in sepsis when mAbs are available. Several studies with respect to the adapter molecules are in progress. In the next 5 years, two new Aims are proposed. First, we plan to begin a new project designed to define the exact role of LPS in sepsis using a systems biology approach. We will begin by infecting a panel of knockout mice, each deficient in a major immune signaling pathway (e.g., MyD88, TRIP, Unc93b, ASC, etc) with a strain of Y pestis in which the acylation pattern of lipid A, as well as the bioactivity, is genetically controlled. LPS from a recombinant strain that is proinflammatory will also be tested vs. the far less inflammatory wild-type LPS. By examining gene expression and cytokine expression in these infected or LPS challenged mice, we will draw an INNATE IMMUNE RESPONSE MAP. Those pathways effected by LPS will be identified and separated from signaling pathways activated in infection independently of LPS. Finally, we will perform forward genetic screening on wild-derived inbred mice to identify new genes involved in LPS responses and use this to refine our Innate Immune Response Map. We believe that these studies will identify those aspects of septic shock that are amenable to anti-LPS therapy in order to help reduce the mortality associated with septic shock.

Public Health Relevance

Gram-negative bacterial sepsis is a syndrome seen after infection with Gram-negative bacteria that can cause life threatening shut down of vital organs. Sepsis is a form of blood poisoning that we think is due to lipopolysaccharide, a lipid made by the cell walls of the bacteria. In this proposal, we seek to define how lipopolysaccharide causes this organ failure and ways in which we can reverse its toxic activity.

Agency
National Institute of Health (NIH)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37GM054060-19
Application #
8686870
Study Section
No Study Section (in-house review) (NSS)
Program Officer
Dunsmore, Sarah
Project Start
Project End
Budget Start
Budget End
Support Year
19
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Worcester
State
MA
Country
United States
Zip Code
01655
Nagpal, Kamalpreet; Plantinga, Theo S; Sirois, Cherilyn M et al. (2011) Natural loss-of-function mutation of myeloid differentiation protein 88 disrupts its ability to form Myddosomes. J Biol Chem 286:11875-82
Meng, Jianmin; Gong, Mei; Bjorkbacka, Harry et al. (2011) Genome-wide expression profiling and mutagenesis studies reveal that lipopolysaccharide responsiveness appears to be absolutely dependent on TLR4 and MD-2 expression and is dependent upon intermolecular ionic interactions. J Immunol 187:3683-93
Meng, Jianmin; Lien, Egil; Golenbock, Douglas T (2010) MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation. J Biol Chem 285:8695-702
Meng, Jianmin; Drolet, Joshua R; Monks, Brian G et al. (2010) MD-2 residues tyrosine 42, arginine 69, aspartic acid 122, and leucine 125 provide species specificity for lipid IVA. J Biol Chem 285:27935-43
Melo, Mariane B; Kasperkovitz, Pia; Cerny, Anna et al. (2010) UNC93B1 mediates host resistance to infection with Toxoplasma gondii. PLoS Pathog 6:e1001071
Seimon, Tracie A; Nadolski, Marissa J; Liao, Xianghai et al. (2010) Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab 12:467-82
Nagpal, Kamalpreet; Plantinga, Theo S; Wong, Joyce et al. (2009) A TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signaling. J Biol Chem 284:25742-8
Halle, Annett; Hornung, Veit; Petzold, Gabor C et al. (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9:857-65
Henneke, Philipp; Dramsi, Shaynoor; Mancuso, Giuseppe et al. (2008) Lipoproteins are critical TLR2 activating toxins in group B streptococcal sepsis. J Immunol 180:6149-58
Meng, Jianmin; Parroche, Peggy; Golenbock, Douglas T et al. (2008) The differential impact of disulfide bonds and N-linked glycosylation on the stability and function of CD14. J Biol Chem 283:3376-84

Showing the most recent 10 out of 12 publications